JP2022553862A5 - - Google Patents

Info

Publication number
JP2022553862A5
JP2022553862A5 JP2022526215A JP2022526215A JP2022553862A5 JP 2022553862 A5 JP2022553862 A5 JP 2022553862A5 JP 2022526215 A JP2022526215 A JP 2022526215A JP 2022526215 A JP2022526215 A JP 2022526215A JP 2022553862 A5 JP2022553862 A5 JP 2022553862A5
Authority
JP
Japan
Application number
JP2022526215A
Other languages
Japanese (ja)
Other versions
JP2022553862A (ja
JPWO2021092491A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/059541 external-priority patent/WO2021092491A1/en
Publication of JP2022553862A publication Critical patent/JP2022553862A/ja
Publication of JPWO2021092491A5 publication Critical patent/JPWO2021092491A5/ja
Publication of JP2022553862A5 publication Critical patent/JP2022553862A5/ja
Pending legal-status Critical Current

Links

JP2022526215A 2019-11-08 2020-11-06 活性剤投与用胃内滞留型システム Pending JP2022553862A (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201962933313P 2019-11-08 2019-11-08
US201962933211P 2019-11-08 2019-11-08
US201962933210P 2019-11-08 2019-11-08
US201962933226P 2019-11-08 2019-11-08
US201962933348P 2019-11-08 2019-11-08
US62/933,211 2019-11-08
US62/933,226 2019-11-08
US62/933,210 2019-11-08
US62/933,348 2019-11-08
US62/933,313 2019-11-08
US202062992075P 2020-03-19 2020-03-19
US62/992,075 2020-03-19
US202063052905P 2020-07-16 2020-07-16
US63/052,905 2020-07-16
PCT/US2020/059541 WO2021092491A1 (en) 2019-11-08 2020-11-06 Gastric residence systems for administration of active agents

Publications (3)

Publication Number Publication Date
JP2022553862A JP2022553862A (ja) 2022-12-26
JPWO2021092491A5 JPWO2021092491A5 (https=) 2023-11-14
JP2022553862A5 true JP2022553862A5 (https=) 2023-11-14

Family

ID=75849597

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022526215A Pending JP2022553862A (ja) 2019-11-08 2020-11-06 活性剤投与用胃内滞留型システム

Country Status (10)

Country Link
US (1) US20220387311A1 (https=)
EP (1) EP4054545A4 (https=)
JP (1) JP2022553862A (https=)
CN (1) CN115003335A (https=)
AU (1) AU2020378438A1 (https=)
BR (1) BR112022008908A2 (https=)
CA (1) CA3160665A1 (https=)
IL (1) IL292849A (https=)
MX (1) MX2022005494A (https=)
WO (1) WO2021092491A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020117855A1 (en) 2018-12-03 2020-06-11 Lyndra, Inc. Stomach simulating device
MX2021011314A (es) 2019-03-20 2021-12-10 Lyndra Therapeutics Inc Capsulas y recubrimientos de capsulas para formas de dosificacion de residencia gastrica.
JP2022525482A (ja) 2019-03-20 2022-05-16 リンドラ セラピューティクス, インコーポレイティド 胃内滞留剤形用のコーティング
CN116234540A (zh) 2020-07-29 2023-06-06 赛康特集团有限责任公司 具有包括交联聚(癸二酸甘油酯)的结构的形状引导控释和滞留
AU2022210426A1 (en) * 2021-01-19 2023-08-24 Nortiva Bio, Inc. Gastric residence systems for administration of risperidone
CA3248763A1 (en) * 2022-01-19 2023-07-27 Nortiva Bio, Inc. Dosage forms for gastric retention
CN115227879B (zh) * 2022-09-15 2023-01-06 北京天星博迈迪医疗器械有限公司 一种用于可降解关节球囊的组合物及其应用、一种可降解关节球囊及其制备方法
WO2024249946A2 (en) * 2023-06-02 2024-12-05 Lyndra Therapeutics, Inc. Manufacturing methods for gastric residence systems
WO2025042350A1 (en) * 2023-08-24 2025-02-27 Junion Therapeutics (Xiamen) Co., Ltd. A gastric residence article for oral administration
WO2025042349A1 (en) * 2023-08-24 2025-02-27 Junion Therapeutics (Xiamen) Co., Ltd. A gastric residence article for oral administration
WO2025148850A1 (zh) * 2024-01-09 2025-07-17 厦门君德医药科技有限公司 一种胃滞留装置
WO2025153071A1 (en) * 2024-01-18 2025-07-24 Junion Therapeutics (Xiamen) Co., Ltd. Gastric residence article for oral administration
WO2025195482A1 (zh) * 2024-03-22 2025-09-25 厦门君德医药科技有限公司 一种胃滞留装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
MX2008009125A (es) * 2006-01-18 2008-10-23 Qps Llc Composiciones farmaceuticas con estabilidad mejorada.
ES2368356T3 (es) * 2007-07-06 2011-11-16 Basf Corporation Composición de retención gástrica basada en un producto de reacción hidrosoluble procedente de un precursor que contiene un grupo vinilo.
JP5905872B2 (ja) * 2010-04-07 2016-04-20 ルピン・リミテッド タペンタドールの制御放出医薬組成物
JP5954669B2 (ja) * 2010-08-06 2016-07-20 エンドゥーシェイプ インコーポレイテッド 医療デバイス用放射線不透過性形状記憶ポリマー
WO2015191922A1 (en) * 2014-06-11 2015-12-17 Massachusetts Institute Of Technology Enteric elastomers
HK1258050A1 (zh) * 2015-10-23 2019-11-01 Lyndra Therapeutics, Inc. 用於治疗剂缓释的胃驻留系统及其使用方法
EP3386488B1 (en) * 2015-12-08 2023-09-06 Lyndra Therapeutics, Inc. Geometric configurations for gastric residence systems
AU2017268840B2 (en) * 2016-05-27 2022-02-10 Nortiva Bio, Inc. Materials architecture for gastric residence systems
US11576866B2 (en) * 2016-09-30 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
US12023406B2 (en) * 2017-06-09 2024-07-02 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
AU2018337837B2 (en) * 2017-09-20 2024-03-07 Nortiva Bio, Inc. Encapsulation of gastric residence systems
KR20220002905A (ko) * 2019-03-25 2022-01-07 더글라스 파머수티클스 리미티드 서방형 약학 제제

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022553867A5 (https=)
JP2022553862A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)